The role of immunological markers in predicting atopic dermatitis in premature infants
Abstract
The aim of the research work was to study the predictor role of the PECAM, H4R and IgG1 allergomarkers in the formation of allergic pathologies in premature infants. The obtained results emphasize the need to determine immunological markers from the first days of life, along with the study of perinatal and neonatal risk factors in predicting atopic diseases. Being higher in children with a developing AtD in comparison with other groups of children, the level of each of these markers in the neonatal period is determined in relation to the statistically verified result of PECAM. The level of H4R is more informative with respect to the severity of AtD and is therefore recommended for use as a predictive marker of disease severity.
References
Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016; 387 (10023): 1109-1122. doi: 10. 1016/S0140-6736(1515)00149-X.
Garritsen FM, Brouwer MW, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. British J Dermatol. 2014; 170: 501.
Global atlas of allergy. Editors: Cezmi A. Akdis, Ioana Agache. Published by the European Academy of Allergy and Clinical Immunology. 2014. 388 p.
Mehta P, Miszta P, Rzodkiewicz P, Michalak O, Krzeczyński P, Filipek S. Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune,and Related Diseases. Life (Basel). 2020. Apr 24;10(4):50. doi: 10.3390/life10040050
Thurmond R.L. The histamine H4 receptor: From orphan to the clinic. Front. Pharmacol. 2015, 6, 65.
Ehling, S, Rossbach K, Dunston SM, Stark H, Baumer W. Allergic inflammation is aug-mented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo. J. Dermatol. Sci. 2016,83, 106–115.
Grosicki M, Kie´c-Kononowicz K. Human eosinophils potential pharmacological model applied in human histamine H4 receptor research. Curr. Med. Chem. 2015, 22, 2087–2099.
De Benedetto A, Yoshida T, Fridy S, Park JE, Kuo IH, Beck LA. Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? J. Clin. Med. 2015, 4, 741–755.
Early M, Schroeder WG, Unnithan R, Gilchrist JM, Muller WA, Schenkel A. Differential effect of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) on leukocyte infiltration during contact hypersensitivity responses. 2017. PeerJ 5:e3555. doi.org/10.7717/peerj.3555
Lobner E, Traxlmayr MW, Obinger C, Hasenhindl C. The crystallizable fragment (Fc) of the immunoglobulin class G (IgG) is a very attractive scaffold for the design of novel therapeutics due to its quality of uniting all essential antibody functions. Immunol Rev. 2016 Mar;270(1):113-31. doi: 10.1111/imr.12385. Engineered IgG1-Fc--one fragment to bind them all.
Keywords
allergy
IgG1
H4R
PECAM (CD31). atopik dermatit
allergiya
IgG1
H4R
PECAM (CD31). атопический дерматит
аллергия
IgG1
H4R
PECAM (CD31)
Most read articles by the same author(s)
- Hasanov S.Sh., Panahova N.F., Hajieva N.N., Kuliyeva S.A. , Agayeva G.T., Assessment of perinatal risk factors in the development of postnatal allergic diseases. , Azerbaijan Journal of Perinatology and Pediatrics: Vol. 6 No. 1 (2020): Journal of Azerbaijan Perinatology and Pediatrics